Arnnon Geshuri - 02 Feb 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
CHIEF PEOPLE OFFICER
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
02 Feb 2023
Net transactions value
-$45,720
Form type
4
Filing time
03 Feb 2023, 15:08:15 UTC
Previous filing
02 Feb 2023
Next filing
07 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $2,048 +750 +1% $2.73* 75,067 02 Feb 2023 Direct F1
transaction TDOC Common Stock Sale $25,500 -750 -1% $34.00 74,317 02 Feb 2023 Direct F1
transaction TDOC Common Stock Options Exercise $2,048 +750 +1% $2.73* 75,067 02 Feb 2023 Direct F1
transaction TDOC Common Stock Sale $24,315 -750 -1% $32.42 74,317 02 Feb 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -750 -0.32% $0.000000 233,778 02 Feb 2023 Common Stock 750 $2.73 Direct F1, F2
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -750 -0.32% $0.000000 233,028 02 Feb 2023 Common Stock 750 $2.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022.
F2 One-fourth of the option vested on December 4, 2018 and 1/48 of the option vests monthly thereafter.